Sector Gamma As Buys Incyte Corp, CVS Health Corp, Alnylam Pharmaceuticals Inc, Sells Bristol-Myers Squibb Company, Abbott Laboratories, Qiagen NV

• New Purchases: CVS, ALNY, LIVN,
• Added Positions: INCY, BMRN, PRGO, ALXN, ANTM, DGX, IONS, ELAN, MRK, UTHR, PDCO,
• Reduced Positions: BMY, ABT, GILD, BIIB, NUVA, BIO, BSX, RARE, PKI, A, BLUE, PTCT, BRKR, CLVS, CAH, HUM,
• Sold Out: QGEN, REGN, UHS, THC, PTLA, AGIO, LLY, SGMO, TAK,

For the details of SECTOR GAMMA AS's stock buys and sells, go to https://www.gurufocus.com/guru/sector+gamma+as/current-portfolio/portfolio

1. Bristol-Myers Squibb Company (BMY) - 677,433 shares, 8.05% of the total portfolio. Shares reduced by 29.83%
2. Incyte Corp (INCY) - 452,583 shares, 7.07% of the total portfolio. Shares added by 60.18%
3. Boston Scientific Corp (BSX) - 970,982 shares, 6.76% of the total portfolio. Shares reduced by 6.37%
4. Abbott Laboratories (ABT) - 370,334 shares, 6.23% of the total portfolio. Shares reduced by 34.57%
5. Merck & Co Inc (MRK) - 372,695 shares, 6.11% of the total portfolio. Shares added by 5.05%

Sector Gamma As initiated holding in CVS Health Corp. The purchase prices were between $52.3 and $76.05, with an estimated average price of $67.09. The stock is now traded at around $63.29. The impact to a portfolio due to this purchase was 1.53%. The holding were 120,860 shares as of .

Sector Gamma As initiated holding in Alnylam Pharmaceuticals Inc. The purchase prices were between $93.12 and $133.99, with an estimated average price of $115.68. The stock is now traded at around $141.54. The impact to a portfolio due to this purchase was 1.26%. The holding were 54,384 shares as of .

Sector Gamma As initiated holding in LivaNova PLC. The purchase prices were between $34.22 and $76.49, with an estimated average price of $65.13. The stock is now traded at around $50.22. The impact to a portfolio due to this purchase was 0.69%. The holding were 71,400 shares as of .

Sector Gamma As added to a holding in Incyte Corp by 60.18%. The purchase prices were between $63.18 and $87.32, with an estimated average price of $75.84. The stock is now traded at around $97.38. The impact to a portfolio due to this purchase was 2.66%. The holding were 452,583 shares as of .

Sector Gamma As added to a holding in Biomarin Pharmaceutical Inc by 86.35%. The purchase prices were between $71.37 and $96.85, with an estimated average price of $86.22. The stock is now traded at around $96.37. The impact to a portfolio due to this purchase was 1.16%. The holding were 139,582 shares as of .

Sector Gamma As added to a holding in Perrigo Co PLC by 30.66%. The purchase prices were between $40.66 and $60.8, with an estimated average price of $53.76. The stock is now traded at around $52.63. The impact to a portfolio due to this purchase was 0.86%. The holding were 356,240 shares as of .

Sector Gamma As added to a holding in Alexion Pharmaceuticals Inc by 33.56%. The purchase prices were between $75.56 and $113.92, with an estimated average price of $98.6. The stock is now traded at around $98.08. The impact to a portfolio due to this purchase was 0.81%. The holding were 168,503 shares as of .

Sector Gamma As added to a holding in Quest Diagnostics Inc by 46.85%. The purchase prices were between $75.14 and $115.68, with an estimated average price of $103.78. The stock is now traded at around $109.88. The impact to a portfolio due to this purchase was 0.62%. The holding were 113,042 shares as of .

Sector Gamma As added to a holding in Ionis Pharmaceuticals Inc by 26.58%. The purchase prices were between $41.6 and $63.4, with an estimated average price of $55.94. The stock is now traded at around $55.84. The impact to a portfolio due to this purchase was 0.58%. The holding were 275,481 shares as of .

Sector Gamma As sold out a holding in Qiagen NV. The sale prices were between $33.17 and $41.6, with an estimated average price of $36.78.

Sector Gamma As sold out a holding in Regeneron Pharmaceuticals Inc. The sale prices were between $336.18 and $494.43, with an estimated average price of $411.31.

Sector Gamma As sold out a holding in Universal Health Services Inc. The sale prices were between $67.69 and $147.78, with an estimated average price of $127.36.

Sector Gamma As sold out a holding in Tenet Healthcare Corp. The sale prices were between $11.01 and $38.35, with an estimated average price of $29.05.

Sector Gamma As sold out a holding in Portola Pharmaceuticals Inc. The sale prices were between $5.78 and $24.74, with an estimated average price of $12.7.

Sector Gamma As sold out a holding in Agios Pharmaceuticals Inc. The sale prices were between $31.52 and $53.81, with an estimated average price of $46.42.